Charter Oak Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $258K | Buy |
10,663
+444
| +4% | +$10.8K | 0.02% | 176 |
|
|
2025
Q1 | $259K | Sell |
10,219
-851
| -8% | -$21.6K | 0.02% | 169 |
|
|
2024
Q4 | $294K | Sell |
11,070
-178
| -2% | -$4.72K | 0.03% | 146 |
|
|
2024
Q3 | $326K | Sell |
11,248
-463
| -4% | -$13.4K | 0.03% | 142 |
|
|
2024
Q2 | $328K | Sell |
11,711
-744
| -6% | -$20.8K | 0.03% | 134 |
|
|
2024
Q1 | $346K | Sell |
12,455
-50
| -0.4% | -$1.39K | 0.04% | 135 |
|
|
2023
Q4 | $360K | Buy |
12,505
+1,011
| +9% | +$29.1K | 0.04% | 126 |
|
|
2023
Q3 | $381K | Sell |
11,494
-155
| -1% | -$5.14K | 0.05% | 119 |
|
|
2023
Q2 | $427K | Buy |
11,649
+647
| +6% | +$23.7K | 0.06% | 116 |
|
|
2023
Q1 | $449K | Buy |
11,002
+824
| +8% | +$33.6K | 0.06% | 111 |
|
|
2022
Q4 | $522K | Sell |
10,178
-477
| -4% | -$24.4K | 0.08% | 95 |
|
|
2022
Q3 | $466K | Sell |
10,655
-7
| -0.1% | -$306 | 0.07% | 100 |
|
|
2022
Q2 | $559K | Sell |
10,662
-535
| -5% | -$28.1K | 0.08% | 101 |
|
|
2022
Q1 | $580K | Buy |
11,197
+13
| +0.1% | +$673 | 0.07% | 110 |
|
|
2021
Q4 | $660K | Buy |
11,184
+17
| +0.2% | +$1K | 0.08% | 103 |
|
|
2021
Q3 | $480K | Buy |
11,167
+3,185
| +40% | +$137K | 0.06% | 112 |
|
|
2021
Q2 | $313K | Buy |
7,982
+72
| +0.9% | +$2.82K | 0.04% | 137 |
|
|
2021
Q1 | $287K | Buy |
7,910
+50
| +0.6% | +$1.81K | 0.04% | 141 |
|
|
2020
Q4 | $289K | Buy |
+7,860
| New | +$289K | 0.04% | 137 |
|